PLUMP
发表于 2025-3-25 04:07:05
http://reply.papertrans.cn/83/8207/820672/820672_21.png
sed-rate
发表于 2025-3-25 11:19:45
http://reply.papertrans.cn/83/8207/820672/820672_22.png
Occipital-Lobe
发表于 2025-3-25 12:37:48
http://reply.papertrans.cn/83/8207/820672/820672_23.png
补助
发表于 2025-3-25 19:21:27
http://reply.papertrans.cn/83/8207/820672/820672_24.png
令人心醉
发表于 2025-3-25 21:57:41
http://reply.papertrans.cn/83/8207/820672/820672_25.png
artless
发表于 2025-3-26 00:29:41
Radioimmunotherapy of Glioblastoma by Using 1-131 and Y-90 Labeled Antitenascin Monoclonal Antibodieignant glioma (anaplastic astrocytoma n.6 and glioblastoma n.16). In 16evaluable patients (12 glioblastoma and 4 anaplastic astrocytoma) the objective response consisted in 1 PD, 4 SD,7 PR,2 CR and 2 NED.The global response rate (PR+ CR+NED) was 68.75% (66.6% in glioblastoma and 75% in anaplastic astrocytoma group).
环形
发表于 2025-3-26 08:12:40
http://reply.papertrans.cn/83/8207/820672/820672_27.png
出处
发表于 2025-3-26 09:37:12
Conference proceedings 1999ecialists in the nuclear medicine, this volume will also be of considerable interest to clinicians using diagnostic and therapeutic nuclear medicine procedures, including cardiologists, haematologists, neurologists, nephrologists, oncologists, pharmacologists, and psychiatrists.
Foreshadow
发表于 2025-3-26 14:28:48
ded for specialists in the nuclear medicine, this volume will also be of considerable interest to clinicians using diagnostic and therapeutic nuclear medicine procedures, including cardiologists, haematologists, neurologists, nephrologists, oncologists, pharmacologists, and psychiatrists.978-3-0348-9772-3978-3-0348-8782-3
盘旋
发表于 2025-3-26 17:29:39
ides in-depth information on all areas of nuclear medicine. The chapters of this volume have been grouped into the following sections: Neurology / Psychiatry, Therapy, Radiopharmacology, Endocrinology / Thyroid, Oncology / Haematology, Clinical PET, Cardiology, Varia, Physics / Radiation Protection,